Head Title

MEG In Pharmaco Symposium 

April 8, 2024: Campus Biotech, Geneva, 10am-2pm

April 8, 2024 - MEGIN has teamed up with Professor Krish Singh (CUBRIC, Cardiff University) to host a MEG in Pharmaco Symposium at the prestigious MEG Lab at Campus Biotech, Geneva.  

Our vision is to have a series of presentations by Key Opinion Leaders who are utilizing MEG in pharmaceutical clinical trials and/or research. The aim is to showcase to our global audience of MEG researchers and pharma industry contacts how MEG can be useful for drug discovery and evaluation work, particularly in terms of showing expected target engagement in early-stage trials. In addition, highlighting how new and existing MEG labs could consider incorporating this type of work, and how pharmaceutical companies could work with MEG experts to incorporate this modality in different phases of drug development.  

Confirmed speakers include: 

Professor Krish Singh, PhD

Professor, Head of Human Electrophysiology, Cardiff University Brain Research Imaging Centre (CUBRIC)

 

Hanna Renvall, PhD

Head of the MEG Lab at BioMag Laboratory at Helsinki University Hospital,

Assistant Professor in Translational Neuroimaging, Aalto University and Helsinki University Hospital

 

Elizabeth Davenport, PhD

Assistant Professor of Radiology

Technical Director for the Magnetoencephalography Center of UT Southwestern Medical Center 

 

Neil Harrison, PhD MRCP MRCPsych

Clinical Professor in Neuroimaging, Cardiff University Brain Research Imaging Centre (CUBRIC)

 

Laura Hughes, PhD

Postdoctoral Fellow, MRC Cognition and Brain Sciences Unit, University of Cambridge

 

More speakers to be announced soon. 

 

Register your interest and receive communications about this free event. Further details will be shared when available with final program and times. Any questions, please email Nicole.Sourry@megin.com 

 

*MEGIN does not endorse any applications or treatments mentioned at this event. Speakers subject to change. TRIUX™ neo is intended to non-invasively locate regions of epileptic activity within the brain and, in conjunction with other diagnostic data, in neurosurgical planning. All other applications are research in nature.

*By submitting your information to register for a Masterclass, MEGIN will use it to communicate with you regarding this event and other services.